Marketview360 Logo
ScreensWatchlistMarketsNewsAI AssistantPricing
⌘K
Marketview360 Logo

The fastest way to screen, analyze, and track US equities. Real-time data, powerful ratios, and clean design for the modern investor.

Product

  • Stock Screener
  • Market Overview
  • Market News
  • AI Assistance

Support

  • Help Center
  • Feedback
  • About
  • Blog
  • System Status

© 2026 Marketview360 Inc. All rights reserved.

PrivacyTermsCookiesDisclaimer
Home/
Screener/
DHR
Danaher Corporation logo

Danaher Corporation

DHR.US
NYSE•Healthcare
Low: $170.19High: $242.80
$181.52
52 Week Range
-3.27%
Market Close
Key Metrics
Peer Comparison
TickerNamePriceMkt CapP/E1D %
ABBV.USAbbVie Inc$410.36B97.92-0.81%
GILD.USGilead Sciences Inc$184.91B21.97-1.92%
BSX.USBoston Scientific Corp$114.04B39.61-1.43%
EXAS.USEXACT Sciences Corporation$19.73B0.00-0.68%
WST.USWest Pharmaceutical Services Inc$18.32B37.46-1.92%
BPMC.USBlueprint Medicines Corp$8.37B0.000.14%
MOH.USMolina Healthcare Inc$7.93B17.273.24%
MMED.USMiniMed Group, Inc. Common Stock$4.48B0.00-5.24%
AMRX.USAmneal Pharmaceuticals, Inc. Class A Common Stock$4.34B1381.00-1.74%
BCRX.USBioCryst Pharmaceuticals Inc$1.87B0.00-2.41%
Latest News

No recent news available for DHR

See news for other symbols →
Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Di…

Sector
Healthcare
Industry
Diagnostics & Research
Employees
58,000
Founded
1979
Country
Not available
Website
https://www.danaher.com
Analyst Ratings
Strong Buy
Target: $264.91(+45.9%)
Based on 26 analysts
0
Strong Sell
0
Sell
3
Hold
4
Buy
19
Strong Buy